Down Syndrome: Interaction between Culture, Demography, and Biology in Determining the Prevalence of a Genetic Trait

Human Biology

Volumn 75, Issue 4, 2003, Pages 503-520

  Olsen, Carolyn L ^a   Cross, Philip K ^b   Gensburg, Lenore J ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Age structure and evolution; Amniocentesis; Down syndrome; Prenatal diagnosis use

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; BIODIVERSITY; BIRTH; BIRTH RATE; COMPARATIVE STUDY; CONCEPTION; CONFERENCE PAPER; CULTURAL ANTHROPOLOGY; DATA ANALYSIS; DECISION MAKING; DEMOGRAPHY; DOWN SYNDROME; EPIDEMIOLOGY; FEMALE; FEMALE FERTILITY; FETUS DEATH; GENETIC TRAIT; GENETICS; HUMAN; INCIDENCE; INFANT; LITERATURE; MATERNAL AGE; MATERNITY WARD; MEDICAL PRACTICE; NEWBORN; PHYSICIAN; PREGNANCY; PRENATAL SCREENING; PREVALENCE; RISK FACTOR; UNITED STATES;

EID: 0344494553     PISSN: 00187143     EISSN: None     Source Type: Journal    
DOI: 10.1353/hub.2003.0059     Document Type: Conference Paper

References (63)

1. Adams, M.M., J.D. Erickson, P.M. Layde et al. 1981. Down's Syndrome: Recent trends in the United States. J. Amer. Med. Assn. 246:758-760.
2. American College of Obstetrics and Gynecology, Committee on Obstetric Practice. 1994. Committee opinion on Down syndrome screening. Washington, D.C.: American College of Obstetrics and Gynecology.
3. American College of Obstetrics and Gynecology, Committee on Practice Bulletins. 2001. Prenatal diagnosis of fetal chromosomal abnormalities: ACOG Practice Bulletin No. 27. Obstet. Gynecol. 97: Suppl. 1-12, pp. 1-11.
4. Baird, P.A., and A.D. Sadovnick. 1988. Maternal age-specific rates for Down Syndrome: Changes over time. Am. J. Med. Genet. 29:917-927.
5. Baird, P. A., A.D. Sadovnick, and B.C. McGillivray. 1985. Temporal changes in the utilization of ammiocentesis for prenatal diagnosis by women of advanced maternal age, 1976-1983. Prenat. Diagn. 5:191-198.
6. Bishop, J., C.A. Huether, C. Torfs et al. 1997. Epidemiologic study of Down syndrome in a racially diverse California population, 1989-1991. Am. J. Epidemiol. 145:134-149.
7. Bogart, M.H., M.R. Pandian, and O.W. Jones. 1987. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat. Diagn. 7:623-630.
8. Bouchard, L., and M. Renaud. 1997. Female and male physicians' attitudes toward prenatal diagnosis: A pan-Canadian survey. Soc. Sci. Med. 44:381-392.
9. Brandenburg, H., C.G. Gho, M.G.J. Jahoda et al. 1992. Effect of chorionic villus sampling on utilization of prenatal diagnosis in women of advanced maternal age. Clin. Genet. 41:239-242.
10. Brigham, J., J. Rifkin, and C.G. Solt. 1993. Birth technologies: Prenatal diagnosis and abortion policy. Politics and the Life Sci. 12:31-44.
11. Centers for Disease Control. 1994. Down Syndrome prevalence at birth-United States, 1983-1990. MMWR 43(33):617-622.
12. Comel, M.C., A.S.P.M. Breed, J.R. Beekhuis et al. 1993. Down Syndrome: Effects of demographic factors and prenatal diagnosis on the future of livebirth prevalence. Hum. Genet. 92:163-168.
13. Cuckle, H.S., and N.J. Wald. 1990. Biochemical screening. Curr. Opin. Obstet. Gynecol. 2:246-252.
14. Ferguson-Smith, M.A. 1983. Prenatal chromosome analysis and its impact on the birth incidence of chromosome disorders. Brit. Med. Bull. 39:355-364.
15. French, B.N., T.W. Kurczynski, M.T. Weaver et al. 1992. Evaluation of the health belief model and decision making regarding amniocentesis in women of advanced maternal age. Health Educ. Qrtly. 19:177-186.
16. Haddow, J.E., and G.E. Palomaki. 1996. Similarities in women's decision-making in the U.S. and U.K. during prenatal diagnosis for Down syndrome. Prenat. Diagn. 16:1161-1162.
17. Haddow, J.E., G.E. Palomaki, G.J. Knight et al. 1992. Prenatal screening for Down syndrome with the use of maternal serum markers. N. Engl. J. Med. 327:588-593.
18. Haddow, J.E., G.E. Palomaki, G.J. Knight et al. 1994. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N. Engl. J. Med. 330:1114-1152.
19. Hecher, K., R. Snijders, and K. Nicolaides. 1993. Screening for fetal chromosomal abnormalities by maternal serum biochemistry and ultrasound examination of fetal morphology. Curr. Opinion Obstet. Gynecol. 5:170-178.
20. Hook, E.B. 1982. Epidemiology of Down Syndrome. In Down Syndrome: Advances in Biomedicine and the Behavioral Sciences, S.M. Pueschel, J.E. Rynders, eds. Cambridge, Ware Press.
21. Hook, E.B., P.K. Cross, and D.M. Schreinemachers. 1981. Evolution of the New York State Chromosome Registry. In Population and Biological Aspects of Human Mutation, E.B. Hook and I.H. Porter, eds. New York, NY: Academic Press.
22. Hook, E.B., and D.M. Schreinemachers. 1983. Trends in utilization of prenatal cytogenetic diagnosis by New York State residents in 1979 and 1980. Am. J. Public Health 73:196-202.
23. Hook, E.B., B. Topol, and P.K. Cross. 1989. The natural history of cytogenetically abnormal fetuses detected at mid trimester amniocentesis which are not terminated electively: New data and estimates of the excess and relative risk of late fetal death associated with 47, +21 and some other abnormal karyotypes. Am. J. Hum. Genet. 45:855-861.
24. Huether, C.A. 1983. Projection of Down Syndrome births in the United States 1979-2000 and the potential effects of prenatal diagnosis. Am. J. Pub. Health 73:1186-1189.
25. Huether, C.A., and G.R. Gummere. 1982. Influence of demographic factors on annual Down's Syndrome births in Ohio, 1970-1979, and the United States, 1920-1979. Am. J. Epidemiol. 115:846-860.
26. Huether, C.A., K. Haroldson, P.M. Ellis et al. 1996. Impact of prenatal diagnosis on revised livebirth prevalence estimates of Down syndrome in Lothian Region of Scotland 1978-92. Genet. Epidemiol 13:367-375.
27. Huether, C.A. J. Ivanovich, B.S. Goodwin et al. 1998. Maternal age-specific risk rate estimates for Down syndrome among livebirths in whites and other races from Ohio and metropolitan Atlanta, 1970-1989. J. Med. Genet. 35:482-490.
28. International Clearinghouse for Birth Defects Monitoring Programs. 1993. Prenatal diagnosis and Down Syndrome, 1993. In Annual Report of the International Clearinghouse for Birth Defects Monitoring Programs (1993). Rome: International Centre for Birth Defects.
29. Kallen, B., and L.B. Knudsen. 1989. Effect of maternal age distribution and prenatal diagnosis on the population rates of Down Syndrome - A comparative study of 19 populations. Hereditas 110:55-60.
30. Kloza, E. 1990. Low MSAFP and new biochemical markers for Down syndrome: Implications for genetic counselors. Birth Def. Orig. Art. Ser. 26:31-43.
31. Knight, G.J., G.E. Palomaki, and J.E. Haddow. 1988. Use of maternal serum alpha-fetoprotein measurements to screen for Down syndrome. Clin. Obstet. Gynecol. 31:306-327.
32. Knutson, C., S.R. Young, R.V. Wade et al. 1989. Utilization of amniocentesis and chorionic villus sampling by South Carolina women 35 years of age and older. J. S. Carolina Med. Assoc. 85:463-467.
33. Krivchenia, E., C.A. Huether, L.D. Edmonds et al. 1993. Comparative epidemiology of Down Syndrome in two United States populations, 1970-1989. Am. J. Epidemiol. 137:815-828.
34. Lillienfeld, A. 1969. Epidemiology of Mongolism. Baltimore, MD: Johns Hopkins Press.
35. Lopez, P.M., D. Stone, and H. Gilmour. 1995. Epidemiology of Down Syndrome in a Scottish city. Paed. Perinat. Epidemiol. 9:331-340.
36. Martin, S.P. 2000. Diverging fertility among United States women who delay childbearing past age 30. Demog. 37:523-533.
37. McDonough, P.A. 1990. The diffusion of genetic amniocentesis in Ontario: 1969-1987. Canada J. Public Health 81:431-435.
38. Merkatz, I.R., H.M. Nitowsky, J.N. Macri et al. 1984. An association between low maternal serum-fetoprotein and fetal chromosomal abnormalities. Am. J. Obstet. Gynecol. 146:886-894.
39. Michie, S., D. Smith, and T.M. Marteau. 1999. Prenatal tests: How are women deciding? Prenat. Diagn. 19:743-748.
40. Mikkelsen, M. 1992. The impact of prenatal diagnosis on the incidence of Down Syndrome in Denmark. Birth Def. Orig. Art. Ser. 28:44-51.
41. Mikkelsen, M., G. Fischer, J. Hansen et al. 1983. The impact of legal termination of pregnancy and of prenatal diagnosis on the live birth prevalence of Down Syndrome in Denmark. Ann. Hum. Genet. 47:123-131.
42. Mutton, D., R.G. Ide, and E.D. Halderman. 1998. Trends in prenatal screening diagnosis of Down syndrome: England and Wales. Brit. Med. J. 317:922-923.
43. Naber, J.M., C.A. Huether, and B.A. Goodwin. 1987. Temporal changes in Ohio amniocentesis utilization during the first twelve years (1972-1983) and frequency of chromosome abnormalities observed. Prenat. Diagn. 7:51-65.
44. Olsen, C.L., and P.K. Cross. 1997. Trends in the use of prenatal diagnosis in New York State and the impact of biochemical screening on the detection of Down syndrome. Prenat. Diagn. 17:1113-1124.
45. Olsen, C.L., P.K. Cross, L.J. Gensburg et al. 1996. The effects of prenatal diagnosis, population ageing and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992. Prenat. Diagn. 16:991-1002.
46. Owens, J.R., F. Harris, S. Walker et al. 1983. The incidence of Down syndrome over a 19-year period with special reference to maternal age. J. Med. Genet. 20:90-93.
47. Palomaki, G.E., J.E. Haddow, and L.J. Beauregard. 1996. Prenatal screening for Down syndrome in Maine, 1980-1993. N. Engl. J. Med. 334:1409-1410.
48. Palomaki, G.E., G.J. Knight, J. McCarthy et al. 1993. Maternal serum screening for fetal Down syndrome in the United States: A 1992 survey. Am. J. Obstet. Gynecol. 169:1558-1562.
49. Palomaki, G.E., G.J. Knight, J.E. McCarthy et al. 1997. Maternal serum screening for Down syndrome in the United States: A 1995 survey. Am. J. Obstet. Gynecol. 176:1046-1057.
50. Paravic, J., B. Brajenovic-Milie, D. Tislaric et al. 1999. Maternal serum screening for Down syndrome: A survey of pregnant women's views. Community Genet. 2:109-112.
51. Penrose, L.S. 1933. The relative effects of paternal and maternal age in mongolism. J. Genet. 27:219-224.
52. Phillips, O.P., S. Elias, L.P. Shulman et al. 1992. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: A prospective 2-year study. Obstet. Gynecol. 80:353-358.
53. Press, N., and C.H. Browner. 1997. Why women say yes to prenatal diagnosis. Soc. Sci. Med. 45: 979-989.
54. Priest, J.H., J.M. FitzGerald, M.M. Haag et al. 1998. Acceptance of amniocentesis by women in the state of Montana (USA) who are screen positive for Down syndrome. J. Med. Screen. 5:178-182.
55. Rae, J.B., Parlington, M.W., and G. Turner. 1989. The utilization of ante natal diagnosis by women of advanced maternal age in the New England Health Region, New South Wales. Med. J. Australia 151:720.
56. Rindfuss, R.R., S.P. Morgan, and K. Offutt. 1996. Education and the changing pattern of American fertility: 1963-1989. Demog. 33:277-290.
57. Rothman, K.J. 1986. Modern Epidemiology. Boston, MA: Little, Brown and Co.
58. Sjogren, B. 1996. Psychological indicators for prenatal diagnosis. Prenat. Diagn. 16:449-454.
59. Staples, A.J., G.R. Sutherland, E.A. Haan et al. 1991. Epidemiology of Down Syndrome in South Australia, 1960-1989. Am. J. Hum. Genet. 49:1014-1024.
60. Stone, D.H., K. Rosenberg, and J. Womersley. 1989. Recent trends in the prevalence and secondary prevention of Down Syndrome. Paed. Perinat. Epidemiol. 3:278-283.
61. Therman, E., and M. Sussman. 1993. Human Chromosomes: Structure, Behavior and Effects. 3rd ed. New York, NY: Springer-Verlag.
62. Ventura, S.J., S.M. Taffel, W.D. Mosher et al. 1995. Trends in pregnancies and pregnancy rates: Estimates for the United States, 1980-1992. National Center for Health Statistics Monthly Vital Statistics Report, Vol. 43, No. 11(s).
63. Wald, N.J., and A. Kennard. 1992. Prenatal biochemical screening for Down syndrome and neural tube defects. Curr. Opin. Obstet. Gynecol. 4:302-307.